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Background & Objectives: Pseudomonas aeruginosa (P.aeruginosa) is a commonly 
isolated pathogen from nosocomial infections worldwide this bacterium has evolved several 
antibiotic resistance mechanisms and antibiotics have failed in treatment of P. aeruginosa 
infections. Hence, immunoprophlaxy and immunotherapy may be an effective method for 
control and treatment of P. aeruginosa infections. In the present study, the immunological 
properties of exotoxin A (domain I,II) was evaluated 
Methods: The DNA encoding for domains I and II of Exotoxin A was amplified by PCR and 
cloned in PET22b expression vector. The construct was then transformed in to E. coli BL21 
and the protein expression was evaluated by SDS-PAGE method. The Ni-NTA affinity 
chromatography was used for recombinant protein purification. The identity of recombinant 
protein was confirmed by western blotting using anti exotoxin A antibody (Sigma). The 
reactivity of recombinant exotoxin A with sera from P.aeruginosa infected patients was used 
for evaluation of immunogenicity. 
Results: The electrophoresis of PCR products on 1% agarose showed 1722 bp band that was 
in accordance with ExoA (domain I- II) gene size. Sequencing of cloned gene showed that 
the sequence of ExoA I-II gene was in accordance with Exo A from P.aeruginosa PAO1. 
SDS-PAGE analysis indicated expression of recombinant protein with a molecular weight of 
approximately 45kDa. Western blotting with anti-exotoxin A antibody (Sigma) verified the 
identity of recombinantly expressed protein. Immunologic analysis using  P.aeruginosa 
infected patients sera showed that the exoA I-II is highly immunogenic protein  that identified 
by patients sera. 
Conclusion: Results of this study showed that recombinant exotoxinA (domainI, II) can be 
tested as a sub-unit vaccine candidate in P. aeruginosa infections. 
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